By Andrew M. Potts The Pharmaceutical Benefits Advisory Committee (PBAC) has rejected a submission to add the human papillomavirus (HPV) vaccine Gardasil to the Pharmaceutical Benefits Scheme (PBS) for use in males. Gardasil is currently only available on the PBS for girls through the National Immunisation Program (NIP) to combat cervical cancer. Last year, drug […]